G Medical Innovations Holdings Ltd
G Medical Innovations Holdings Ltd
Your view on GMVDF
Overview
What the company does, where it operates, and who runs it.
About G Medical Innovations Holdings Ltd
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Yacov Geva
- Headquarters
- 5 Oppenheimer Street, Rehovot, IL
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Yacov Geva
- Headquarters
- 5 Oppenheimer Street, Rehovot, IL
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel.
The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days.
It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services.
G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for G Medical Innovations Holdings Ltd, and the rating behind it. GMVDF last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for G Medical Innovations Holdings Ltd. Starting points for G Medical Innovations Holdings Ltd: EPS -$34.17, beta -1.18 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for G Medical Innovations Holdings Ltd. G Medical Innovations Holdings Ltd does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for G Medical Innovations Holdings Ltd. Trailing twelve-month EPS for G Medical Innovations Holdings Ltd stands at -$34.17. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for G Medical Innovations Holdings Ltd. G Medical Innovations Holdings Ltd has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
G Medical Innovations Holdings Ltd valued side by side against its closest peers. G Medical Innovations Holdings Ltd is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold G Medical Innovations Holdings Ltd, and how their positions are changing. At a $25,992 market value, institutional positions materially move G Medical Innovations Holdings Ltd's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by G Medical Innovations Holdings Ltd executives and directors. Shares of G Medical Innovations Holdings Ltd have traded between $0.0000 and $0.03 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming G Medical Innovations Holdings Ltd. G Medical Innovations Holdings Ltd is a $25,992 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming G Medical Innovations Holdings Ltd. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for G Medical Innovations Holdings Ltd. Coverage tracks G Medical Innovations Holdings Ltd within Medical - Devices (Healthcare). Press releases and market coverage, newest first.